Form4insider filings, from the source

SEC Form 4 · accession 0001567619-18-007453

Kura Oncology, Inc. · KURA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Dec 3, 2018
Accepted (ET)
Dec 6, 2018 · 7:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422143

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 3, 2018P48,182$13.97A4,108,467D
Common StockDec 4, 2018P54,645$13.08A4,163,112D
Common StockDec 6, 2018P17,079$13.49A4,180,919D

Table II — derivative securities

No Table II lines on this filing.